Showing 6141-6160 of 8668 for: Cochrane Systematic Reviews Back
- Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation
Cochrane Systematic Reviews, 14-Apr-2014
Preterm prelabour rupture of membranes (PPROM) is associated with increased risk of maternal and neonatal morbidity and mortality. Women with PPROM have been predominantly managed in hospital. It is possible that selected women could be managed at home af
- Planned hospital birth versus planned home birth
Cochrane Systematic Reviews, 25-Nov-2013
Observational studies of increasingly better quality and in different settings suggest that planned home birth in many places can be as safe as planned hospital birth and with less intervention and fewer complications. This is an update of a Cochrane revi
- Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting
Cochrane Systematic Reviews, 10-Feb-2021
Dementia is a syndrome that comprises many differing pathologies, including Alzheimer's disease dementia (ADD), vascular dementia (VaD) and frontotemporal dementia (FTD). People may benefit from knowing the type of dementia they live with, as this could i
- Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
Cochrane Systematic Reviews, 10-Jun-2014
According to the latest revised National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association) (NINCDS-ADRDA) diagnostic criteria for Alzhe
- Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 2-Nov-2017
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an uncommon progressive or relapsing paralysing disease caused by inflammation of the peripheral nerves. If the hypothesis that it is due to autoimmunity is correct, removal of autoantibo
- Plasma exchange for generalised myasthenia gravis
Cochrane Systematic Reviews, 15-Mar-2011
Myasthenia gravis is an autoimmune disease mediated by auto-antibodies most often directed against the nicotinic acetylcholine receptor. Less than five per cent of patients have auto-antibodies to a muscle tyrosine kinase. Patients would be expected to be
- Plasma exchange for Guillain‐Barré syndrome
Cochrane Systematic Reviews, 27-Feb-2017
Guillain-Barré syndrome (GBS) is an acute paralysing disease caused by peripheral nerve inflammation. This is an update of a review first published in 2001 and last updated in 2012.
- Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis
Cochrane Systematic Reviews, 28-Jun-2019
Plasma volume expanders are used in connection to paracentesis in people with cirrhosis to prevent reduction of effective plasma volume, which may trigger deleterious effect on haemodynamic balance, and increase morbidity and mortality. Albumin is conside
- Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults
Cochrane Systematic Reviews, 30-Apr-2019
The definition of sepsis has evolved over time, along with the clinical and scientific knowledge behind it. For years, sepsis was defined as a systemic inflammatory response syndrome (SIRS) in the presence of a documented or suspected infection. At presen
- Plasma transfusion strategies for critically ill patients
Cochrane Systematic Reviews, 28-Dec-2013
Although plasma transfusions are frequently prescribed for critically ill patients, most clinical uses of plasma are not supported by evidence. Plasma transfusions do not seem to correct mild coagulation abnormalities based on international normalised rat
- Plasma transfusions prior to insertion of central lines for people with abnormal coagulation
Cochrane Systematic Reviews, 20-Sep-2016
The insertion of central venous catheters (CVCs) may be associated with peri- and post-procedural bleeding. People who require a central line often have disorders of coagulation as a result of their underlying illness, co-morbidities or the effects of tre
- Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation
Cochrane Systematic Reviews, 25-Sep-2017
The insertion of a lumbar puncture needle or epidural catheter may be associated with peri- and post-procedural bleeding. People who require this procedure may have disorders of coagulation as a result of their underlying illness, co-morbidities or the ef
- Plasma volume expansion for suspected impaired fetal growth
Cochrane Systematic Reviews, 21-Oct-1996
Failure of the normal expansion of plasma volume in the mother is associated with impaired fetal growth and pre-eclampsia.
- Plasma volume expansion for treatment of pre‐eclampsia
Cochrane Systematic Reviews, 25-Oct-1999
Plasma volume is reduced amongst women with pre-eclampsia. This association has led to the suggestion that expanding the plasma volume might improve maternal and uteroplacental circulation, and so potentially improve outcome for both the woman and her bab
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Cochrane Systematic Reviews, 26-Apr-2017
Current guidelines recommend screening of people with oesophageal varices via oesophago-gastro-duodenoscopy at the time of diagnosis of hepatic cirrhosis. This requires that people repeatedly undergo unpleasant invasive procedures with their attendant ris
- Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
Cochrane Systematic Reviews, 7-Nov-2013
During percutaneous coronary intervention (PCI), and in non-ST segment elevation acute coronary syndromes (NSTEACS), the risk of acute vessel occlusion by thrombosis is high. Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may pre
- Platelet rich therapies for long bone healing in adults
Cochrane Systematic Reviews, 25-May-2012
The morbidity and socioeconomic costs associated with long bone healing are considerable. Platelet-rich therapies are autologous blood products with a greater concentration of platelets than physiological whole blood. Despite promising results from a numb
- Platelet-rich therapies for musculoskeletal soft tissue injuries
Cochrane Systematic Reviews, 28-Apr-2014
Platelet-rich therapies are being used increasingly in the treatment of musculoskeletal soft tissue injuries such as ligament, muscle and tendon tears and tendinopathies. These therapies can be used as the principal treatment or as an augmentation procedu
- Platelet‐rich‐plasmapheresis for minimising peri‐operative allogeneic blood transfusion
Cochrane Systematic Reviews, 16-Mar-2011
Concerns regarding the safety of transfused blood have generated considerable enthusiasm for the use of technologies intended to reduce the use of allogeneic blood (blood from an unrelated donor). Platelet-rich plasmapheresis (PRP) offers an alternative a
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
Cochrane Systematic Reviews, 2-Aug-2015
Small cell lung cancer (SCLC) is a very fast growing form of cancer and is characterised by early metastasis. As a result, chemotherapy is the mainstay of treatment. A number of different platinum-based chemotherapy regimens and non-platinum-based chemoth
